NCT06354244

Brief Summary

The aim of this study is to compare the effects of electroacupuncture of different frequency in patients with chronic urinary retention caused by lower motor neuron lesions

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

April 4, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 9, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

April 3, 2024

Last Update Submit

May 12, 2024

Conditions

Keywords

electroacupuncturechronic urinary retentioncohort study

Outcome Measures

Primary Outcomes (1)

  • The response rate.

    Responders are defined as patients whose post void residuals (PVR) reduced by 50% or more from baseline.

    Week 12.

Secondary Outcomes (7)

  • The response rate.

    Week 4, Week 8 and Week 24.

  • The change in post void residuals (PVR) from baseline.

    Week 4, Week 8,Week 12 and Week 24.

  • The change in the proportion of patients reporting severe urinating difficulty from baseline.

    Week 4, Week 8,Week 12 and Week 24.

  • The change in the proportion of patients having stool retention from baseline.

    Week 4, Week 8,Week 12 and Week 24.

  • The change in the proportion of patients requiring catheterization from baseline.

    Week 4, Week 8,Week 12 and Week 24.

  • +2 more secondary outcomes

Study Arms (3)

Electroacupuncture of 2 sessions per week

Device: Electroacupuncture of 2 sessions per week

Electroacupuncture of 3 sessions per week

Device: Electroacupuncture of 3 sessions per week

Electroacupuncture of 4 sessions per week

Device: Electroacupuncture of 4 sessions per week

Interventions

Acupoints including bilateral BL23, BL32, BL33, BL35 and SP6 are inserted with acupuncture needles(size 0.30 × 40 mm and 0.30 × 75 mm or 0.40 × 100 mm,Hwato Brand). Bilateral BL32 and BL33 are needled to a depth of 70-95 mm with an angle of 60°-75° inward and downward, into the second and third sacral foramen. Bilateral BL35 are needled to a depth of 60-70 mm in a slightly superolateral direction. Bilateral BL23 and SP6 are vertically needled to a depth of 25-30 mm. After deqi is evoked, electric stimulators with a 5Hz continuous wave (5-10 mA intensity) are separately connected to bilateral BL32, BL33,BL35 and SP6. Current intensity is adjusted according to the patients' individual tolerance. During each session, electroacupuncture(EA) is retained for 30 minutes. The patients receive EA 2 sessions per week for 2-24 weeks.EA can be terminated if the patient acquire satisfactory spontaneous urination.

Electroacupuncture of 2 sessions per week

Acupoints and electroacupuncture (EA) procedures are the same as in the group of EA of 2 sessions per week, but the patients receive EA 3 sessions per week for 2-24 weeks in this group.EA can be terminated if the patient acquire satisfactory spontaneous urination.

Electroacupuncture of 3 sessions per week

Acupoints and electroacupuncture (EA) procedures are the same as in the group of EA of 2 sessions per week, but the patients receive EA 4 sessions per week for 2-24 weeks in this group.EA can be terminated if the patient acquire satisfactory spontaneous urination.

Electroacupuncture of 4 sessions per week

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

There are a group of patients with nerve lesions presenting with chronic urinary retention, having to rely on life-long catheterization to empty the bladder. However, complications of catheterization including recurrent urinary tract infection and urethral stricture formation, negatively impact on patients' daily life and bring heavy burden on family and society, together making it a less ideal option.

You may qualify if:

  • Diagnosed with urinary retention caused by lower motor neuron lesions (e.g., sacral plexus, cauda equina, or sacral cord lesions).
  • years or older.
  • Baseline post void residuals (PVR) ≥150 mL.
  • The course of urinary retention ≥1 month.
  • Having normal bladder sensation.
  • Using clean intermittent catheterization (CIC), indwelling catheterization (IC), manual assisted voiding including putting pressure on abdomen, or cystostomy catheterization.
  • Signed informed consent and voluntary participation in the study.

You may not qualify if:

  • Having a lower urinary tract obstruction, such as bladder neck contracture, urethral stricture, prostatic hyperplasia, or large urinary stones that can cause obstruction.
  • Having any type of malignant tumors not removed.
  • Having severe systemic disorders not controlled.
  • Having implanted electrodes of cardiac pacemaker, pudendal nerve stimulation, bladder stimulation, or SNM.
  • Pregnancy or lactation.
  • Eletroacupuncture treatment duration \< 2 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Beijing, China

RECRUITING

MeSH Terms

Conditions

Urinary Retention

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 3, 2024

First Posted

April 9, 2024

Study Start

April 4, 2024

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

May 14, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Deidentified participant data and data dictionary will be available with the publication until six months after publication. A formal request should be sent to zhishunjournal@163.com with a methodologically sound proposal. Researchers whose proposal has been approved will sign a data access agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
The data will be available with the publication until six months after publication.
Access Criteria
A formal request should be sent to zhishunjournal@163.com with a methodologically sound proposal. Researchers whose proposal has been approved. Researchers whose proposal has been approved will sign a data access agreement.

Locations